Search
for
Sort by
Research 601–630 of 1000+
- Novel causes of drug-induced occupational asthma
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Self-Emulsifying Drug Delivery Systems (SEDDS): Measuring Energy Dynamics to Determine Thermodynamic and Kinetic Stability
- Niosomes: A Novel Targeted Drug Delivery System
- DNN-DTIs: improved drug-target interactions prediction using XGBoost feature selection and deep neural network
- Entrepreneurship in Off-Label Drug Prescription: Just What the Doctor Ordered!
- Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol.
- Production of ultraviolet-light-induced skin erythema in the hairless rat: a comparison with the haired rat in screening for anti-inflammatory drugs
- A computer‐aided drug repurposing: the antibacterial agents targeting GroEL
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Ensuring safety in cytotoxic drug preparation: A systematic review of guidelines addressing education for pharmacy professionals
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- The metabolic effects of drugs used for the treatment of polycystic ovary syndrome
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Disease modifying osteoarthritis drug discovery using a temporal phenotypic reporter in 3D aggregates of primary human chondrocytes
- Screening of dermatology drugs for aberrant use‐patterns: An application of epidemiologic estimates and measures of inequality in drug use
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- Utility of homoeopathic drug phosphorus in management of alopecia areata: An evidence based case report
- Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking
- When bugs and drugs conspire: driving acneiform skin toxicity
- Can we halt male androgenetic alopecia progression without antiandrogenic drugs?
- Anti-Androgen Drugs in the Treatment of Obsessive-Compulsive Disorder: A Systematic Review
- Use of the drug Wolvit® (biotin 5 mg) in treatment of defuse telogenous alopecia
- Over-the-counter drugs against hair loss
- Ixekizumab improves physical function, quality of life, and work productivity in biologic disease-modifying antirheumatic drug-naive patients with active psoriatic arthritis